1-2 of 2
Roberto Tapia, BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Alisertib (MLN8237), an Oral Selective Inhibitor of Aurora Kinase a, Has Clinical Activity and Restores GATA1 Expression in Patients with Myelofibrosis

Naseema Gangat, MBBS, Brady Lee Stein, MD, Christian Marinaccio, Ronan Swords, MD PhD, Justin M. Watts, MD, Sandeep Gurbuxani, Olga Frankfurt, MD, Jessica K. Altman, MD, Jeremy Q. Wen, MD PhD, Noushin Farnoud, PhD, Christopher Famulare, MS, Akshar Patel, BA, Roberto Tapia, BS, Amy Handlogten, Yvonne Trang Dinh, BS, Kristen Englund, Shradha Patel, Juan Carlos Nobrega, Dalissa Tejera, MSN, Amber Thomassen, Harald Stein, MD PhD Dr. h.c., Juehua Gao, MD PhD, Peng Ji, MDPhD, Raajit K. Rampal, MD PhD, Francis J. Giles, MD FRCPI, FRCPath, Ayalew Tefferi, MD, John D. Crispino, PhD MBA
Journal: Blood
Blood (2018) 132 (Supplement 1): 688.
https://doi.org/10.1182/blood-2018-99-110381
Published: 2018
Journal Articles

A Multicenter, Open-Label, Pilot Study of Alisertib (MLN8237), a Novel Inhibitor of Aurora Kinase a, in Myelofibrosis

Naseema Gangat, MBBS, Ronan T. Swords, MD PhD FRCPI, FRCPath, Brady Lee Stein, MDMHS, Christian Marinaccio, Justin M Watts, MD, Olga Frankfurt, MD, Jessica K. Altman, MD, Aref Al-Kali, MD, Darci Zblewski, CNP, Sandeep Gurbuxani, Jeremy Q. Wen, MD PhD, Roberto Tapia, BS, Stephanie Barath, Amy Graf, Amy Handlogten, Yvonne Trang Dinh, BS, Kristen Englund, Shradha Patel, Orlando Bodes, Jillian Ogden, Francis J. Giles, MD MB, FRCPath, Ayalew Tefferi, MD, John D. Crispino, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1631.
https://doi.org/10.1182/blood.V130.Suppl_1.1631.1631
Published: 2017